SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Lee Edward T (Last) (First) (Middle) C/O RH 15 KOCH ROAD, SUITE K (Street) CORTE MADERA CA 94925 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/14/2020	3. Issuer Name and Ticker or Trading Symbol RH [ RH ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) See Remarks	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,504	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	04/20/2026	Common Stock	10,000	44.52	D
Stock Option (Right to Buy)	(2)	06/26/2026	Common Stock	3,000	25.39	D
Stock Option (Right to Buy)	(3)	04/01/2029	Common Stock	5,000	101.25	D
Stock Option (Right to Buy)	(4)	04/28/2030	Common Stock	4,000	154.82	D
Stock Option (Right to Buy)	(5)	05/05/2025	Common Stock	740	87.31	D
Restricted Stock Unit (RSU)	(6)	(6)	Common Stock	2,000	(7)	D

Explanation of Responses:

1. This option award is vested and exercisable with respect to 5,000 of the shares and will vest and become exercisable with respect to an additional 5,000 shares on April 21, 2021, subject to continuous service.

2. This option award is vested and exercisable with respect to 1,500 of the shares and will vest and become exercisable with respect to an additional 1,500 shares on June 27, 2021, subject to continuous service.

3. This option award is vested and exercisable with respect to 500 of the shares and will vest and become exercisable with respect to an additional 750 shares on April 2, 2021, an additional 750 shares on April 2, 2022, an additional 1,000 shares on April 2, 2023 and an additional 2,000 shares on April 2, 2024, subject to continuous service.

4. This option award will vest and become exercisable with respect to 400 shares on April 29, 2021, an additional 400 shares on April 29, 2022, an additional 400 shares on April 29, 2023, an additional 600 shares on April 29, 2024, an additional 600 shares on April 29, 2025, an additional 800 shares on April 29, 2026, and an additional 800 shares on April 29, 2027, subject to continuous service.

5. This option award is fully vested and exercisable.

6. This restricted stock unit award will vest with respect to all 2,000 remaining units on June 16, 2021, subject to continuous service.

7. Each restricted stock unit represents a contingent right to receive one share of RH common stock.

Remarks:

Chief Legal and Compliance Officer

	/s/ Edward T. Lee	10/21/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.